BRCA1GENE EXPRESSION IN ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT

Results of molecular genetic study of BRCA1gene expression in patients with endocrine tumors of the gastrointestinal tract were presented. Based on the analysis of survival rates in patients with endocrine tumors of the gastrointestinal tract, the BRCA1expression level was suggested can be used as a...

Full description

Bibliographic Details
Main Authors: I. G. Gafton, Е. N. Imyanitov, V. V. Semiglasov, D. Е. Matsko, G. I. Gafton, Yu. V. Semiletova, А. G. Ievleva, А. Е. Mikhnin, V. G. Lemekhov
Format: Article
Language:Russian
Published: Tomsk National Research Medical Center of the Russian Academy of Sciences 2016-02-01
Series:Sibirskij Onkologičeskij Žurnal
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/60
id doaj-977422c9bd4444218ee01a9f9bb3bd50
record_format Article
spelling doaj-977422c9bd4444218ee01a9f9bb3bd502021-07-28T21:01:59ZrusTomsk National Research Medical Center of the Russian Academy of SciencesSibirskij Onkologičeskij Žurnal1814-48612312-31682016-02-0104111560BRCA1GENE EXPRESSION IN ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACTI. G. Gafton0Е. N. Imyanitov1V. V. Semiglasov2D. Е. Matsko3G. I. Gafton4Yu. V. Semiletova5А. G. Ievleva6А. Е. Mikhnin7V. G. Lemekhov8N.N. Petrov Research Institute of Oncology, St.-Petersburg I.P. Pavlov State Medical University, St.-PetersburgI.I. Mechnikov State Medical University, St.-PetersburgN.N. Petrov Research Institute of Oncology, St.-Petersburg I.P. Pavlov State Medical University, St.-PetersburgN.N. Petrov Research Institute of Oncology, St.-PetersburgN.N. Petrov Research Institute of Oncology, St.-PetersburgN.N. Petrov Research Institute of Oncology, St.-Petersburg I.I. Mechnikov State Medical University, St.-PetersburgN.N. Petrov Research Institute of Oncology, St.-PetersburgN.N. Petrov Research Institute of Oncology, St.-Petersburg I.I. Mechnikov State Medical University, St.-PetersburgN.N. Petrov Research Institute of Oncology, St.-Petersburg I.I. Mechnikov State Medical University, St.-PetersburgResults of molecular genetic study of BRCA1gene expression in patients with endocrine tumors of the gastrointestinal tract were presented. Based on the analysis of survival rates in patients with endocrine tumors of the gastrointestinal tract, the BRCA1expression level was suggested can be used as a prognostic criterion and as a factor determining the advisability of administration of platinum-based drugs. It was found that the more aggressive neuroendocrine tumors had the lower BRCA1expression. Therefore, administration of platinumcontaining chemotherapy is unlikely to offer any benefit for these patients.https://www.siboncoj.ru/jour/article/view/60neuroendocrine tumorsbrca1 expressionchemotherapy
collection DOAJ
language Russian
format Article
sources DOAJ
author I. G. Gafton
Е. N. Imyanitov
V. V. Semiglasov
D. Е. Matsko
G. I. Gafton
Yu. V. Semiletova
А. G. Ievleva
А. Е. Mikhnin
V. G. Lemekhov
spellingShingle I. G. Gafton
Е. N. Imyanitov
V. V. Semiglasov
D. Е. Matsko
G. I. Gafton
Yu. V. Semiletova
А. G. Ievleva
А. Е. Mikhnin
V. G. Lemekhov
BRCA1GENE EXPRESSION IN ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT
Sibirskij Onkologičeskij Žurnal
neuroendocrine tumors
brca1 expression
chemotherapy
author_facet I. G. Gafton
Е. N. Imyanitov
V. V. Semiglasov
D. Е. Matsko
G. I. Gafton
Yu. V. Semiletova
А. G. Ievleva
А. Е. Mikhnin
V. G. Lemekhov
author_sort I. G. Gafton
title BRCA1GENE EXPRESSION IN ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT
title_short BRCA1GENE EXPRESSION IN ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT
title_full BRCA1GENE EXPRESSION IN ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT
title_fullStr BRCA1GENE EXPRESSION IN ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT
title_full_unstemmed BRCA1GENE EXPRESSION IN ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT
title_sort brca1gene expression in endocrine tumors of the gastrointestinal tract
publisher Tomsk National Research Medical Center of the Russian Academy of Sciences
series Sibirskij Onkologičeskij Žurnal
issn 1814-4861
2312-3168
publishDate 2016-02-01
description Results of molecular genetic study of BRCA1gene expression in patients with endocrine tumors of the gastrointestinal tract were presented. Based on the analysis of survival rates in patients with endocrine tumors of the gastrointestinal tract, the BRCA1expression level was suggested can be used as a prognostic criterion and as a factor determining the advisability of administration of platinum-based drugs. It was found that the more aggressive neuroendocrine tumors had the lower BRCA1expression. Therefore, administration of platinumcontaining chemotherapy is unlikely to offer any benefit for these patients.
topic neuroendocrine tumors
brca1 expression
chemotherapy
url https://www.siboncoj.ru/jour/article/view/60
work_keys_str_mv AT iggafton brca1geneexpressioninendocrinetumorsofthegastrointestinaltract
AT enimyanitov brca1geneexpressioninendocrinetumorsofthegastrointestinaltract
AT vvsemiglasov brca1geneexpressioninendocrinetumorsofthegastrointestinaltract
AT dematsko brca1geneexpressioninendocrinetumorsofthegastrointestinaltract
AT gigafton brca1geneexpressioninendocrinetumorsofthegastrointestinaltract
AT yuvsemiletova brca1geneexpressioninendocrinetumorsofthegastrointestinaltract
AT agievleva brca1geneexpressioninendocrinetumorsofthegastrointestinaltract
AT aemikhnin brca1geneexpressioninendocrinetumorsofthegastrointestinaltract
AT vglemekhov brca1geneexpressioninendocrinetumorsofthegastrointestinaltract
_version_ 1721263486064918528